Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 3, 2017
Clinical News

Linzess: Ph III data

BioCentury | Dec 21, 2016
Clinical News

Linzess regulatory update

BioCentury | Feb 29, 2016
Clinical News

Linzess regulatory update

BioCentury | Dec 7, 2015
Clinical News

Linzess: Phase II data

BioCentury | Dec 1, 2015
Clinical News

Ironwood's linaclotide meets in OIC study

BioCentury | Oct 26, 2015
Clinical News

Linzess: Phase III data

BioCentury | Jul 13, 2015
Clinical News

Linzess: Phase III data

BioCentury | Nov 17, 2014
Clinical News

Linzess linaclotide: Phase III started

BioCentury | Nov 3, 2014
Clinical News

Linzess linaclotide: Phase II started

BioCentury | Apr 21, 2014
Clinical News

Constella linaclotide regulatory update

Items per page:
1 - 10 of 14